Susu
92 Cours Lafayette, Lyon, Cedex 03, 69489, France
Overview
Susu uses technology to deliver care bundles and a 360° digital platform that connects patients, medical providers, internal teams, and financial contributors. Its care bundles combine SMS medical advice, nurse visits, doctor consultations, and other activities to support chronic and preventive care such as diabetes and hypertension. The company offers a financing solution allowing patients to pay bills plus a monthly subscription that can be paid or contributed to by family members in the diaspora via its transaction platform. Founded in 2019, Susu already serves over 7,000 clients across Côte d’Ivoire, Senegal, and Cameroon. With the $4.9M raise it plans to accelerate growth by expanding into other Francophone African markets and North Africa, diversify acquisition into corporate and financial institutions, and enhance its digital platform. Susu will also expand its workforce and reinforce marketing, operations, and finance teams in France and Africa by 2024. Susu is an Ivorian and French-based healthtech that offers care packages or bundles tailored to patients with chronic diseases (diabetes, hypertension) and pregnant women, combining doctor consultations, nurse visits and SMS medical advice. The product enables patients to finance bills and introduces a collective financing option where family members locally or in the diaspora can pay subscription fees. Susu was founded in 2019 by Bola Bardet with Laurent Leconte (CTO) and Sandrine Egron (COO). The company serves customers in Ivory Coast, Senegal and Cameroon and plans to launch services in six more sub-Saharan African countries, including Nigeria and Ghana. Its customer base is about 5,000 users, which grew 5x last year, and reported revenue growth of more than 400% in 2021. Susu intends to use new funding to grow the team and introduce additional product features to scale across Africa.
- Total raised
- $7M
- Funding rounds
- 3
- Latest round
- Equity
- Latest activity
- Dec 2023
Industries
- Biotechnology
- Emergency Medicine
- Health Care
- Health Insurance
- Wellness
Recent funding
Equity
Dec 2023
$5M
Debt Financing
Mar 2022
$1M